Theravance Biopharma, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG8807B1068
USD
17.02
0.08 (0.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
296.72
175.54
213.00
441.80
-338.57
-303.75
Shareholder's Funds
296.72
175.54
213.00
441.80
-338.57
-303.75
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
43.74
10.71
3.92
6.75
616.84
629.04
Secured Loans
43.74
10.71
3.92
6.75
616.84
629.04
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
85.68
75.20
65.29
64.19
0.24
0.00
Other Long Term Liabilities
117.75
146.53
144.24
136.88
55.41
49.4
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
150.55
146.53
144.24
136.88
654.81
649.24
Current Liabilities
Trade Payables
2.57
2.24
1.52
1.55
3.10
6.78
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
38.30
32.09
24.77
28.71
58.59
123.57
Total Liabilities
485.57
354.16
382.00
607.40
374.82
469.06
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
54.09
58.17
66.94
84.84
91.84
105.49
Less: Accumulated Depreciation
23.82
22.40
21.58
32.84
38.49
45.81
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
30.27
35.77
45.35
52.00
53.35
59.68
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
14.35
3.13
0.84
0.84
68.37
0.83
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
22.50
154.19
202.27
201.10
3.23
15.20
Total Non-Current Assets
67.11
193.09
248.46
253.94
124.95
75.72
Current Assets Loans & Advances
Current Investments
147.55
50.55
62.88
29.31
83.51
211.47
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
95.54
68.44
17.47
16.79
14.06
15.87
Cash and Bank
167.81
37.80
39.55
298.17
89.96
81.47
Other Current Assets
410.90
156.79
119.90
344.27
231.06
362.61
Short Term Loans and Advances
0.00
0.00
0.00
0.00
43.53
53.80
Total Current Assets
418.46
161.07
133.54
353.46
249.87
393.34
Net Current Assets (Including Current Investments)
380.16
128.98
108.77
324.75
191.28
269.77
Total Current Assets Excluding Current Investments
418.46
161.07
133.54
353.46
249.87
393.34
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
485.57
354.16
382.00
607.40
374.82
469.06
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
43.74
10.71
3.92
6.75
616.84
629.04
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Compare Balance Sheet Results of Theravance Biopharma, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
296.72
103.08
193.64
187.85%
Shareholder's Funds
296.72
103.08
193.64
187.85%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
43.74
0.55
43.19
7,852.73%
Secured Loans
43.74
0.55
43.19
7,852.73%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
85.68
0
85.68
0.00%
Other Long Term Liabilities
117.75
28.73
89.02
309.85%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
150.55
28.73
121.82
424.02%
Current Liabilities
Trade Payables
2.57
13.16
-10.59
-80.47%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
38.30
28.64
9.66
33.73%
Total Liabilities
485.57
160.46
325.11
202.61%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
54.09
0
54.09
0.00%
Less: Accumulated Depreciation
23.82
0
23.82
0.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
30.27
3.05
27.22
892.46%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
14.35
60.61
-46.26
-76.32%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
22.50
0.49
22.01
4,491.84%
Total Non-Current Assets
67.11
64.14
2.97
4.63%
Current Assets Loans & Advances
Current Investments
147.55
70.79
76.76
108.43%
Inventories
0
0
0.00
0.00%
Sundry Debtors
95.54
5.57
89.97
1,615.26%
Cash and Bank
167.81
19.96
147.85
740.73%
Other Current Assets
410.90
96.32
314.58
326.60%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
418.46
96.32
322.14
334.45%
Net Current Assets (Including Current Investments)
380.16
67.67
312.49
461.79%
Total Current Assets Excluding Current Investments
418.46
96.32
322.14
334.45%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
485.57
160.46
325.11
202.61%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
43.74
0.55
43.19
7,852.73%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Investments
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period